image
Healthcare - Biotechnology - NASDAQ - US
$ 363.25
-5.96 %
$ 16.2 B
Market Cap
15.97
P/E
BALANCE SHEET
7.17 B ASSETS
18.57%
1.18 B LIABILITIES
-5.26%
5.98 B EQUITY
24.77%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition United Therapeutics Corporation
image
Current Assets 3.55 B
Cash & Short-Term Investments 2.99 B
Receivables 279 M
Other Current Assets 278 M
Non-Current Assets 3.62 B
Long-Term Investments 1.91 B
PP&E 1.05 B
Other Non-Current Assets 661 M
Current Liabilities 804 M
Accounts Payable 5.6 M
Short-Term Debt 400 M
Other Current Liabilities 399 M
Non-Current Liabilities 378 M
Long-Term Debt 300 M
Other Non-Current Liabilities 77.8 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998
ASSETS
Cash & Cash Equivalents 1 207.7 961.2 894.8 738.7 738.4 669.2 705.1 1 023.0 831.8 397.7 278.9 154.0 162.7 252.2 100.4 129.5 139.3 91.1 69.2 82.6 68.6 122.7 24.4 200.9 18.3 6.8
Short Term Investments 1 786.4 1 877.5 1 035.9 1 096.3 747.5 746.7 222.3 27.8 122.0 297.8 409.6 325.2 240.8 374.9 129.1 106.6 150.7 136.7 56.3 0.2 0 0 31.7 14.5 33.3 0
Receivables 278.9 220.4 198.7 157.4 151.4 175.7 297.1 214.5 192.8 162.3 126.3 116.6 88.7 73.7 53.3 30.6 29.7 25.6 19.0 15.8 10.6 9.7 4.2 2.4 0.4 100 K
Inventory 111.8 102.0 93.8 86.5 93.4 101.0 107.9 100.0 81.3 66.9 47.8 37.3 46.0 35.5 26.4 14.4 13.2 12.0 11.3 8.0 8.1 7.2 6.0 2.9 0 0
Other Current Assets 166.2 219.2 100.4 88.3 133.8 75.4 115.5 59.5 169.4 49.4 46.4 35.4 24.3 28.2 15.4 16.4 19.5 11.9 11.0 3.9 2.4 2.4 2.7 1.5 0.7 9.9
Total Current Assets 3 551.0 3 380.3 2 323.6 2 167.2 1 864.5 1 768.0 1 447.9 1 424.8 1 275.3 974.2 909.0 668.5 562.5 765.1 324.5 297.4 352.5 277.4 166.8 110.5 89.7 141.9 69.0 222.1 52.7 16.8
PP&E 1 045.4 861.5 780.9 731.6 738.5 699.7 545.7 489.3 495.8 478.4 464.9 453.7 366.0 306.0 303.9 221.1 69.4 34.7 21.8 17.8 15.2 9.1 6.4 5.9 3.8 1.3
Intangible Assets 80.5 16.5 16.6 130.1 130.3 139.3 31.9 23.5 18.1 19.2 3.4 5.9 14.0 7.4 9.7 0.4 1.0 3.1 13.0 13.4 13.9 14.5 15.4 17.5 2.7 0
Goodwill 33.7 28.0 28.0 28.0 28.0 31.5 13.7 10.3 10.3 10.3 10.7 10.5 8.1 2.5 8.8 7.5 7.5 7.5 7.5 7.5 0 7.5 0 0 0 0
Long Term Investments 1 909.8 1 316.2 1 649.9 1 149.6 767.5 442.6 502.7 2.3 38.0 122.8 453.5 311.1 349.0 138.0 188.6 146.0 9.7 36.4 44.9 46.2 0 10.0 116 249.0 0 0 0
Other Long Term Assets 151.8 114.3 108.2 169.9 154.6 224.2 224.1 197.1 154.3 97.8 53.3 26.8 27.7 10.6 15.2 23.0 53.3 52.6 29.9 65.4 60.6 19.1 121.4 5.0 0.7 0.6
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 7 167.0 6 044.5 5 169.1 4 615.0 3 913.4 3 401.0 2 879.4 2 325.6 2 184.4 1 884.4 2 087.6 1 626.6 1 518.1 1 431.6 1 051.5 871.3 587.0 478.6 291.4 207.2 179.5 184.6 212.1 250.6 59.9 18.7
LIABILITIES
Accounts Payable 5.6 4.1 3.8 4.1 9.9 23.1 8.4 8.1 7.5 7.0 6.7 10.2 47.3 16.1 18.8 20.3 2.0 2.8 4.0 6.1 4.3 3.0 6.7 6.0 2.3 1.7
Short Term Debt 400.0 0 0 0 250.0 0 0 0 5.4 126.4 282.5 0 0 236.0 220.3 0 250.0 10 K 15 K 16 K 0.8 0.1 0.1 70.8 K 100 K 0
Other Current Liabilities 398.8 339.1 301.6 319.2 203.1 253.5 436.3 324.4 427.9 370.9 398.5 166.6 165.3 176.6 91.2 37.5 20.7 16.4 10.5 7.8 5.5 6.2 4.0 5.5 2.2 100 K
Total Current Liabilities 804.4 343.2 305.4 323.3 463.0 276.6 444.7 332.5 440.8 504.3 687.7 176.8 212.6 428.7 330.2 57.8 272.8 19.2 14.5 13.9 10.6 9.3 10.8 11.5 4.6 1.8
Long Term Debt 300.0 800.0 800.0 800.0 600.0 250.0 250.0 0 0 0 3.7 275.0 194.2 68.9 30.3 279.2 2 K 250.0 8 K 20 K 25 K 1.8 1.8 1.8 1.8 0.3
Deferred Tax Income 0 41.0 30.0 27.4 45.5 53.3 19.1 31.7 34.5 0 0 0 0 0 0 0 0 1.6 0 0 0 0 0 0 0 0
Other Liabilities 77.8 104.6 104.8 96.5 70.0 66.6 63.7 130.9 144.0 114.5 91.9 80.0 162.8 50.1 38.0 26.6 18.5 3.1 1.8 1.6 1.1 1.8 3.1 2.6 100 K 100 K
Total Liabilities 1 182.2 1 247.8 1 210.2 1 219.8 1 133.0 612.4 777.6 463.4 584.8 618.8 783.3 531.7 569.6 547.7 398.5 363.6 291.2 273.9 16.3 15.5 11.7 12.9 15.7 15.9 6.3 2.0
EQUITY
Common Stock 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.6 0.6 0.6 0.6 0.6 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0
Retained Earnings 6 027.1 5 042.3 4 315.0 3 839.2 3 325.2 3 434.8 2 845.6 2 433.5 1 719.8 1 068.1 728.0 553.5 249.0 31.2 (74.7) (78.5) (21.5) (41.4) (115.3) (180.3) (195.4) (185.8) (162.2) (124.9) (49.3) (15.8)
Other Accumulative Comprehensive Income/Loss (12.8) (55.5) (23.0) (14.2) (14.2) (7.9) (19.6) (16.8) (20.4) (16.7) (13.2) (15.0) (10.9) (9.2) (4.3) (5.9) 0.3 1.5 3.6 2.7 1.7 8 K (1.4) (0.5) (0.2) 0
Total Equity 5 984.8 4 796.7 3 958.9 3 395.2 2 780.4 2 788.6 2 101.8 1 862.2 1 599.6 1 265.6 1 304.3 1 094.9 948.5 883.9 653.0 507.7 295.8 204.6 275.1 191.6 167.8 171.7 196.4 234.7 53.6 16.7
Total Liabilities and Equity 7 167.0 6 044.5 5 169.1 4 615.0 3 913.4 3 401.0 2 879.4 2 325.6 2 184.4 1 884.4 2 087.6 1 626.6 1 518.1 1 431.6 1 051.5 871.3 587.0 478.6 291.4 207.2 179.5 184.6 212.1 250.6 59.9 18.7
SHARES OUTSTANDING
Common Shares Outstanding 46.8 45.5 44.9 44.2 43.8 43.5 44.0 43.8 46.0 48.2 50.1 52.1 57.2 56.1 53.3 45.8 42.4 46.0 45.6 43.5 42.3 41.3 40.6 38.5 26.7 16.6